The global pharmaceutical industry has committed an additional £2 billion ($2.70 billion) to the UK since September 2025, according to the Association of the British Pharmaceutical Industry (ABPI), which benchmarks the country against 12 leading markets on more than 40 international metrics in its 2026 competitiveness report.Read More
ABPI reports £2 billion UK investment rebound as NHS drug spending rises
